Feb 28, 2024 / 01:00PM GMT
Antje Witte - UCB SA - Head of IR
Good morning, good afternoon and good evening. Welcome to the UCB Full Year 2023 Capital Markets Call. This is Antje from the Investor Relations team.
Before I introduce you to the agenda and hand over to the speakers today, I'd like to make some remarks. This presentation and the following Q&A session are intended for institutional capital market participants. If you're not, please disconnect now. This video conference is being recorded. This presentation and the following Q&A session are covered by the disclaimer and safe harbor statement as stated on the Slide 2 of the slide deck, please read this carefully. You can find the presentation in our download center in case on our website in case you would dial in by phone.
With this, I'd like you to introduce to our speakers for today, our CEO, Jean-Christophe Tellier; Emmanuel Caeymaex, Executive Vice President, Immunology and Head of the U.S. Iris Low-Friedrich, Chief Medical Officer; and the CFO, Sandrine Dufour. In the Q&A session, not only the speakers will be there to answer your
Full Year 2023 Ucb SA Earnings Call Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers